Home Cart Sign in  
Chemical Structure| 19202-36-9 Chemical Structure| 19202-36-9

Structure of Hinokiflavone
CAS No.: 19202-36-9

Chemical Structure| 19202-36-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hinokiflavone is a SUMO protease inhibitor that inhibits the activity of Sentrin-specific protease 1 (SENP1). Hinokiflavone has obvious cytotoxicity and can inhibit MMP-9 activity.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Hinokiflavone

CAS No. :19202-36-9
Formula : C30H18O10
M.W : 538.46
SMILES Code : O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C(OC4=CC=C(C5=CC(C6=C(O)C=C(O)C=C6O5)=O)C=C4)C(O)=C13
MDL No. :MFCD00017455

Safety of Hinokiflavone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
LO2 0, 10, 20, 40, 80, 120, 160, 240, 320 µmol/L 24, 48, 72 hours HF showed much lower cytotoxicity against LO2 cells, with IC50 values of 159.1 ± 5.6 µmol/L (24 hours), 104.7 ± 4.5 µmol/L (48 hours), and 75.7 ± 2.8 µmol/L (72 hours). J Cell Mol Med. 2020 Jul;24(14):8151-8165
HepG2 0, 10, 20, 30, 40, 60, 80, 100 µmol/L 24, 48, 72 hours HF significantly inhibited the proliferation of HepG2 cells, with IC50 values of 80.8 ± 2.6 µmol/L (24 hours), 57.5 ± 5.3 µmol/L (48 hours), and 28.1 ± 2.7 µmol/L (72 hours). HF induced G0/G1 phase cell cycle arrest by up-regulating the p53/p21Cip1 signaling pathway and down-regulating G0/G1 phase-related cell cycle regulatory proteins. J Cell Mol Med. 2020 Jul;24(14):8151-8165
SMMC-7721 0, 10, 20, 30, 40, 60, 80, 100 µmol/L 24, 48, 72 hours HF significantly inhibited the proliferation of SMMC-7721 cells, with IC50 values of 74.4 ± 8.1 µmol/L (24 hours), 60.3 ± 2.9 µmol/L (48 hours), and 33.0 ± 2.6 µmol/L (72 hours). HF induced G0/G1 phase cell cycle arrest by up-regulating the p53/p21Cip1 signaling pathway and down-regulating G0/G1 phase-related cell cycle regulatory proteins. J Cell Mol Med. 2020 Jul;24(14):8151-8165
Human lung adenocarcinoma A549 cells 20 μg/mL 24 hours To measure mitochondrial membrane potential, the mitochondrial membrane potential in the HF hybrid micelles group was significantly decreased compared with that in the free HF group, indicating that HF hybrid micelles could induce mitochondria-mediated apoptosis. Drug Deliv. 2020 Dec;27(1):565-574
Human lung adenocarcinoma A549 cells 0.78 μg/mL to 50 μg/mL 24 hours To evaluate the cytotoxicity of HF hybrid micelles on A549 cells, the results showed that the IC50 value of HF hybrid micelles (7.81 μg/mL) was lower than that of free HF (19.34 μg/mL), indicating that HF hybrid micelles had higher cytotoxicity. Drug Deliv. 2020 Dec;27(1):565-574
HeLa cells 500 μM 90 minutes Inhibited splicing of Ad1 and HPV18 E6 pre-mRNAs, preventing formation of the B complex Elife. 2017 Sep 8;6:e27402
AML-2 cells 0–25 μM 24 hours Hinokiflavone attenuated the ubiquitination levels of MDM2 and p53 in AML-2 cells. Biomolecules. 2022 Apr 27;12(5):643
Klebsiella pneumoniae clinical isolates 0.25-0.5 µg/mL Evaluate the antibacterial activity of Hinokiflavone against Klebsiella pneumoniae, showing the highest antibacterial activity Pharmaceuticals (Basel). 2021 Aug 1;14(8):756
HT-29 cells 1-10 μM 24 hours To evaluate the inhibitory effect of Hinokiflavone on LPS-induced inflammatory responses, results showed that Hinokiflavone suppressed the production of IL-8 and downregulated the expression of iNOS and COX-2. Molecules. 2018 Apr 17;23(4):926
RAW 264.7 cells 1-10 μM 24 hours To evaluate the inhibitory effect of Hinokiflavone on LPS-induced inflammatory responses, results showed that Hinokiflavone suppressed the production of NO, IL-6, TNF-α, and downregulated the expression of iNOS and COX-2. Molecules. 2018 Apr 17;23(4):926
S. aureus USA300 64 μg/mL Assess the effect of Hinokiflavone on the growth of S. aureus USA300, showing no effect on bacterial growth at 64 mg/mL. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022
HEK293T cells 256 μg/mL 24 hours Evaluate the cytotoxicity of Hinokiflavone on HEK293T cells, showing no cytotoxicity at 256 mg/mL. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022
3T3-L1 cells 10 μM Assessed the effect of HF on apoptosis in differentiated 3T3-L1 cells, showing HF induced apoptosis via mitochondrial pathway J Biol Chem. 2024 Sep;300(9):107721

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c-nu mice HCC xenograft model Intraperitoneal injection 4 or 8 mg/kg Every other day for ten times HF significantly inhibited the growth of HCC xenografts, with the average tumour size reduced to 831.8 mm3 and 523 mm3 in the 4 mg/kg and 8 mg/kg groups, respectively, compared to 1604 mm3 in the control group. HF up-regulated the expression levels of cleaved PARP, cleaved caspase-3, and p-JNK, and apoptosis was confirmed by TUNEL assay. J Cell Mol Med. 2020 Jul;24(14):8151-8165
BALB/c nude mice A549 xenograft tumor model Oral administration 80 mg/kg Administered on days 2, 4, 6, 8, 10, and 12, lasting for 12 days To evaluate the in vivo antitumor effect of HF hybrid micelles, the results showed that the tumor volume and weight in the HF hybrid micelles group were significantly lower than those in the free HF group and the control group, with a tumor inhibition rate of 64.76%, significantly higher than that in the free HF group (45.92%). Drug Deliv. 2020 Dec;27(1):565-574
C57BL/6J mice MRSA-induced lethal pneumonia model Subcutaneous injection 100 mg/kg/d Every 12 hours for 96 hours Evaluate the protective effect of Hinokiflavone against MRSA-induced lethal pneumonia, showing more potent than vancomycin alone when combined with vancomycin. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022
C57BL/6J mice High-fat diet-induced obesity model Intraperitoneal injection 5 mg/kg, 10 mg/kg, 20 mg/kg Administered every other day for 6 weeks HF suppressed obesity by inducing apoptosis in adipose tissue, improving glucose tolerance and insulin sensitivity J Biol Chem. 2024 Sep;300(9):107721

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.86mL

0.37mL

0.19mL

9.29mL

1.86mL

0.93mL

18.57mL

3.71mL

1.86mL

References

 

Historical Records

Categories